IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematological oncology 2017-06, Vol.35 (S2), p.410-410
Hauptverfasser:	Bonnet, C.M., Lamy, T., Fruchart, C., Legouill, S., Gunzer, K., Gastinne, T., Jardin, F., Karlin, L., Houot, R., Dupuis, J., Tilly, H., Salles, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	B-cell lymphoma Inhibitor drugs Lymphocytes B Lymphoma Patients Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	410
container_issue	S2
container_start_page	410
container_title	Hematological oncology
container_volume	35
creator	Bonnet, C.M. Lamy, T. Fruchart, C. Legouill, S. Gunzer, K. Gastinne, T. Jardin, F. Karlin, L. Houot, R. Dupuis, J. Tilly, H. Salles, G.
description
doi_str_mv	10.1002/hon.2439_188
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1906625758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1906625758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1498-f3524455df7c46d3b151784fadadb69f863ed6b1333184080ee32592c2dad9663</originalsourceid><addsrcrecordid>eNp9kL1u2zAURomiBeqm3foABLpGNn8kmuxGyXRFgBYFUUbribAtCU2Q2I6UoMiWR8iY58uThIGdjJ3ucM5378UHwHeMxhghMvm7341JTIXHnH8AI4yEiDBi4iMYITLlESKUfAZfhuESocAQH4EnnVbLWhc6hbqA0jmbaVlrW8Dfus5h9fzwOMtlObF_4NxWsAxMFbU7UWVk6dRsUql5JbPaViuYhkSmjIFmtShzu5A_YRk8vdCFDLhSbmlC3s5hnSuY6tRYB8tcOgXDD2blJHT1crb6Cj5166uh_XaaZ2A5V3WWR8b-0pk00RbHgkcdTUgcJ0nTTbcxa-gGJ3jK427drJsNEx1ntG3YBlNKMY8RR21LSSLIlgRBMEbPwI_j3kO_v7lrh1t_ub_rd-GkxwIxRpJpwoN1frS2_X4Y-rbzh_7iet3fe4z8a_c-dO_fug96ctT_XVy19_91fW6L99wLs899fQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1906625758</pqid></control><display><type>article</type><title>IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bonnet, C.M. ; Lamy, T. ; Fruchart, C. ; Legouill, S. ; Gunzer, K. ; Gastinne, T. ; Jardin, F. ; Karlin, L. ; Houot, R. ; Dupuis, J. ; Tilly, H. ; Salles, G.</creator><creatorcontrib>Bonnet, C.M. ; Lamy, T. ; Fruchart, C. ; Legouill, S. ; Gunzer, K. ; Gastinne, T. ; Jardin, F. ; Karlin, L. ; Houot, R. ; Dupuis, J. ; Tilly, H. ; Salles, G.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.2439_188</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>B-cell lymphoma ; Inhibitor drugs ; Lymphocytes B ; Lymphoma ; Patients ; Targeted cancer therapy</subject><ispartof>Hematological oncology, 2017-06, Vol.35 (S2), p.410-410</ispartof><rights>2017 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.2439_188$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.2439_188$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids></links><search><creatorcontrib>Bonnet, C.M.</creatorcontrib><creatorcontrib>Lamy, T.</creatorcontrib><creatorcontrib>Fruchart, C.</creatorcontrib><creatorcontrib>Legouill, S.</creatorcontrib><creatorcontrib>Gunzer, K.</creatorcontrib><creatorcontrib>Gastinne, T.</creatorcontrib><creatorcontrib>Jardin, F.</creatorcontrib><creatorcontrib>Karlin, L.</creatorcontrib><creatorcontrib>Houot, R.</creatorcontrib><creatorcontrib>Dupuis, J.</creatorcontrib><creatorcontrib>Tilly, H.</creatorcontrib><creatorcontrib>Salles, G.</creatorcontrib><title>IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY</title><title>Hematological oncology</title><subject>B-cell lymphoma</subject><subject>Inhibitor drugs</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Patients</subject><subject>Targeted cancer therapy</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kL1u2zAURomiBeqm3foABLpGNn8kmuxGyXRFgBYFUUbribAtCU2Q2I6UoMiWR8iY58uThIGdjJ3ucM5378UHwHeMxhghMvm7341JTIXHnH8AI4yEiDBi4iMYITLlESKUfAZfhuESocAQH4EnnVbLWhc6hbqA0jmbaVlrW8Dfus5h9fzwOMtlObF_4NxWsAxMFbU7UWVk6dRsUql5JbPaViuYhkSmjIFmtShzu5A_YRk8vdCFDLhSbmlC3s5hnSuY6tRYB8tcOgXDD2blJHT1crb6Cj5166uh_XaaZ2A5V3WWR8b-0pk00RbHgkcdTUgcJ0nTTbcxa-gGJ3jK427drJsNEx1ntG3YBlNKMY8RR21LSSLIlgRBMEbPwI_j3kO_v7lrh1t_ub_rd-GkxwIxRpJpwoN1frS2_X4Y-rbzh_7iet3fe4z8a_c-dO_fug96ctT_XVy19_91fW6L99wLs899fQ</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Bonnet, C.M.</creator><creator>Lamy, T.</creator><creator>Fruchart, C.</creator><creator>Legouill, S.</creator><creator>Gunzer, K.</creator><creator>Gastinne, T.</creator><creator>Jardin, F.</creator><creator>Karlin, L.</creator><creator>Houot, R.</creator><creator>Dupuis, J.</creator><creator>Tilly, H.</creator><creator>Salles, G.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201706</creationdate><title>IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY</title><author>Bonnet, C.M. ; Lamy, T. ; Fruchart, C. ; Legouill, S. ; Gunzer, K. ; Gastinne, T. ; Jardin, F. ; Karlin, L. ; Houot, R. ; Dupuis, J. ; Tilly, H. ; Salles, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1498-f3524455df7c46d3b151784fadadb69f863ed6b1333184080ee32592c2dad9663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>B-cell lymphoma</topic><topic>Inhibitor drugs</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Patients</topic><topic>Targeted cancer therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonnet, C.M.</creatorcontrib><creatorcontrib>Lamy, T.</creatorcontrib><creatorcontrib>Fruchart, C.</creatorcontrib><creatorcontrib>Legouill, S.</creatorcontrib><creatorcontrib>Gunzer, K.</creatorcontrib><creatorcontrib>Gastinne, T.</creatorcontrib><creatorcontrib>Jardin, F.</creatorcontrib><creatorcontrib>Karlin, L.</creatorcontrib><creatorcontrib>Houot, R.</creatorcontrib><creatorcontrib>Dupuis, J.</creatorcontrib><creatorcontrib>Tilly, H.</creatorcontrib><creatorcontrib>Salles, G.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonnet, C.M.</au><au>Lamy, T.</au><au>Fruchart, C.</au><au>Legouill, S.</au><au>Gunzer, K.</au><au>Gastinne, T.</au><au>Jardin, F.</au><au>Karlin, L.</au><au>Houot, R.</au><au>Dupuis, J.</au><au>Tilly, H.</au><au>Salles, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY</atitle><jtitle>Hematological oncology</jtitle><date>2017-06</date><risdate>2017</risdate><volume>35</volume><issue>S2</issue><spage>410</spage><epage>410</epage><pages>410-410</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.2439_188</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0278-0232
ispartof	Hematological oncology, 2017-06, Vol.35 (S2), p.410-410
issn	0278-0232 1099-1069
language	eng
recordid	cdi_proquest_journals_1906625758
source	Wiley Online Library Journals Frontfile Complete
subjects	B-cell lymphoma Inhibitor drugs Lymphocytes B Lymphoma Patients Targeted cancer therapy
title	IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T18%3A35%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IBRUTINIB%20IN%20ASSOCIATION%20WITH%20R%E2%80%90DHAP/OX%20FOR%20PATIENTS%20WITH%20RELAPSED/REFRACTORY%20B%E2%80%90CELL%20LYMPHOMA:%20PRELIMINARY%20RESULTS%20OF%20THE%20BIBLOS%20PHASE%20IB%20LYSA%20STUDY&rft.jtitle=Hematological%20oncology&rft.au=Bonnet,%20C.M.&rft.date=2017-06&rft.volume=35&rft.issue=S2&rft.spage=410&rft.epage=410&rft.pages=410-410&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.2439_188&rft_dat=%3Cproquest_cross%3E1906625758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1906625758&rft_id=info:pmid/&rfr_iscdi=true